4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-024699
SVP, Chief Accounting Officer sold 132 shares at $84.55 ($11,161)
From the SEC's structured data for this filing
Trades in this filing
Huizenga Theodore Alan · SVP, Chief Accounting Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-04-16 | Sale : show line 1 in the form | −132 | $84.55 | $11,161 | 16,914 | D |
| Open-market sales · 132 sh · avg $84.55 · $11,161 | ||||||
Loading xslF345X03/doc4.xml…